Pfizer-BioNTech submits new COVID booster to the FDA for emergency-use authorization. The vaccine targets the omicron subvariant BA.5. https://t.co/xK1aDD4DXy
Pfizer-BioNTech submits new COVID booster targeting BA.5 to the FDA for authorization